NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Rhea-AI Summary
NEXGEL (NASDAQ:NXGL) will report first quarter 2026 financial results for the period ended March 31, 2026 on Friday, May 15, 2026.
Management will host a conference call at 12:00 P.M. ET, with phone and webcast access plus replay options.
Positive
- None.
Negative
- None.
News Market Reaction – NXGL
In the May 12 session, NXGL declined 4.13%, reflecting a moderate negative market reaction. Argus tracked a peak move of +7.7% during that session. Argus tracked a trough of -7.0% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 25 | Earnings date set | Neutral | -1.0% | Announced Q4 and full-year 2025 results date and earnings call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date news saw a small negative reaction of about -0.97%, suggesting limited standalone impact from scheduling announcements.
Over recent months, NEXGEL announced multiple corporate and strategic developments, including the Celularity regenerative biomaterials acquisition backed by a $5.5 million investment and the launch of BioNX Surgical, plus new board and CFO appointments. These moves aimed to expand its product portfolio and operations. Against this backdrop, the current first quarter 2026 earnings-date announcement on May 15, 2026 follows a pattern of routine scheduling updates similar to the prior Q4 and full-year 2025 earnings-date notice on March 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day
LANGHORNE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2026 ended March 31, 2026, on Friday, May 15, 2026. Following the release of its financial results, the Company will host a conference call at 12:00 P.M. ET on the same day.
First Quarter 2026 Financial Results Conference Call:
Date: May 15, 2026
Time: 12:00 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: Events and Presentations
For interested individuals unable to join the conference call, a replay will be available through May 29, 2026, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11161819. An archived version of the webcast will also be available for 90 days.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com
